[DPHARMA] QoQ TTM Result on 30-Jun-2017 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
25-Aug-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
30-Jun-2017 [#2]
Profit Trend
QoQ- 27.23%
YoY- -2.29%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Revenue 477,940 467,987 429,767 394,690 354,464 312,940 328,308 28.47%
PBT 52,929 51,796 45,270 38,579 32,714 31,479 42,709 15.39%
Tax -9,746 -9,696 -5,416 -3,626 -5,098 -4,653 -9,379 2.59%
NP 43,183 42,100 39,854 34,953 27,616 26,826 33,330 18.86%
-
NP to SH 43,710 42,492 40,548 35,484 27,890 27,115 34,022 18.19%
-
Tax Rate 18.41% 18.72% 11.96% 9.40% 15.58% 14.78% 21.96% -
Total Cost 434,757 425,887 389,913 359,737 326,848 286,114 294,978 29.54%
-
Net Worth 206,429 479,809 474,230 463,071 463,071 454,703 451,913 -40.71%
Dividend
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Div 23,711 23,711 7,085 7,085 19,142 19,142 8,084 105.03%
Div Payout % 54.25% 55.80% 17.47% 19.97% 68.64% 70.60% 23.76% -
Equity
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Net Worth 206,429 479,809 474,230 463,071 463,071 454,703 451,913 -40.71%
NOSH 278,959 278,959 278,959 278,959 278,959 278,959 278,959 0.00%
Ratio Analysis
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
NP Margin 9.04% 9.00% 9.27% 8.86% 7.79% 8.57% 10.15% -
ROE 21.17% 8.86% 8.55% 7.66% 6.02% 5.96% 7.53% -
Per Share
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
RPS 171.33 167.76 154.06 141.49 127.07 112.18 117.69 28.47%
EPS 15.67 15.23 14.54 12.72 10.00 9.72 12.20 18.17%
DPS 8.50 8.50 2.54 2.54 6.86 6.86 2.90 104.94%
NAPS 0.74 1.72 1.70 1.66 1.66 1.63 1.62 -40.71%
Adjusted Per Share Value based on latest NOSH - 278,959
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
RPS 49.65 48.61 44.64 41.00 36.82 32.51 34.10 28.49%
EPS 4.54 4.41 4.21 3.69 2.90 2.82 3.53 18.28%
DPS 2.46 2.46 0.74 0.74 1.99 1.99 0.84 104.82%
NAPS 0.2144 0.4984 0.4926 0.481 0.481 0.4723 0.4694 -40.71%
Price Multiplier on Financial Quarter End Date
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Date 30/03/18 29/12/17 29/09/17 30/06/17 31/03/17 30/12/16 30/09/16 -
Price 2.80 2.53 2.20 2.25 2.31 1.98 2.06 -
P/RPS 1.63 1.51 1.43 1.59 1.82 1.76 1.75 -4.62%
P/EPS 17.87 16.61 15.14 17.69 23.10 20.37 16.89 3.83%
EY 5.60 6.02 6.61 5.65 4.33 4.91 5.92 -3.64%
DY 3.04 3.36 1.15 1.13 2.97 3.47 1.41 66.97%
P/NAPS 3.78 1.47 1.29 1.36 1.39 1.21 1.27 107.05%
Price Multiplier on Announcement Date
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Date 28/05/18 28/02/18 17/11/17 25/08/17 22/05/17 24/02/17 21/11/16 -
Price 3.35 2.97 2.20 2.03 2.32 2.23 2.10 -
P/RPS 1.96 1.77 1.43 1.43 1.83 1.99 1.78 6.63%
P/EPS 21.38 19.50 15.14 15.96 23.20 22.94 17.22 15.53%
EY 4.68 5.13 6.61 6.27 4.31 4.36 5.81 -13.43%
DY 2.54 2.86 1.15 1.25 2.96 3.08 1.38 50.24%
P/NAPS 4.53 1.73 1.29 1.22 1.40 1.37 1.30 130.02%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment